BC THROMBIN REAGENT 10446636

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2017-09-01 for BC THROMBIN REAGENT 10446636 manufactured by Siemens Healthcare Diagnostics Products Gmbh.

Event Text Entries

[85369819] Siemens healthcare diagnostics inc. (siemens) is investigating the cause of the variability in thrombin time (tt) results between different reagent and control lots. The bcs xp system reference guide states that "reference intervals vary from laboratory to laboratory depending on the population, the technique and reagent lot. Therefore, each laboratory must establish its own reference intervals or verify them whenever one or more of the aforementioned variables are changed. " differences in seconds for normal patient results due to the dependency on the reagent lot used potentially contributed to the variability in tt results. Mdr 9610806-2017-00095 was filed for the same event.
Patient Sequence No: 1, Text Type: N, H10


[85369820] Elevated thrombin time (tt) patient sample results were obtained on the bcs xp system with bc thrombin lot 517468 (kit lot # 46751) and reported to the physician(s), who questioned the results. The customer indicated that the elevated tt results may potentially lead to a delay in planned patient treatment, but no patients were clinically impacted. The customer indicated the average tt results for normal patients increased with bc thrombin lot 517468 compared to bc thrombin lot 517467. The customer did not provide any patient data for evaluation. Although within range of the tables of assigned values, the customer observed an increase in the internal quality control (qc) for bc thrombin lot 517468 and bc thrombin lot 517469 compared to bc thrombin lot 517467, with the allowable total error (tea) sometimes exceeding the laboratory's specification of 10%. External quality controls (riqas and cobjwdl) were run between march and july of 2017 on bc thrombin lots 517468 and 517469 and recovered above the expected value(s). Based on the variability in quality control recovery, the lab stopped running the thrombin time tests on patient samples. There are no known reports of patient intervention or adverse health consequences due to the elevated tt results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9610806-2017-00094
MDR Report Key6839145
Date Received2017-09-01
Date of Report2017-10-18
Date of Event2017-03-06
Date Mfgr Received2017-09-20
Date Added to Maude2017-09-01
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactCHRISTINA LAM
Manufacturer Street511 BENEDICT AVE
Manufacturer CityTARRYTOWN NY 10591
Manufacturer CountryUS
Manufacturer Postal10591
Manufacturer Phone9145243504
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer StreetEMIL-VON-BEHRING-STR. 76
Manufacturer CityMARBURG, D-35041
Manufacturer CountryGM
Manufacturer Postal CodeD-35041
Single Use3
Previous Use Code3
Removal Correction Number9610806-10/18/2017-003-C
Event Type3
Type of Report0

Device Details

Brand NameBC THROMBIN REAGENT
Generic NameBC THROMBIN REAGENT
Product CodeGJA
Date Received2017-09-01
Model NumberBC THROMBIN REAGENT
Catalog Number10446636
Lot Number46751
Device Expiration Date2018-09-08
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer AddressEMIL-VON-BEHRING-STR. 76 MARBURG, D-35041 GM D-35041


Patients

Patient NumberTreatmentOutcomeDate
10 2017-09-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.